| # | Drug | Count |
|---|---|---|
| 0 | VARENICLINE TARTRATE | 16 |
| 1 | AMLODIPINE | 5 |
| 2 | ESTRADIOL | 4 |
| 3 | METOPROLOL | 4 |
| 4 | METOPROLOL TARTRATE | 4 |
| 5 | METOPROLOL TARTRATE INJECTION | 4 |
| 6 | PROGESTERONE | 4 |
| 7 | PANTOPRAZOLE | 3 |
| 8 | PREGABALIN | 3 |
| 9 | GABAPENTIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLUNISAL | 1 | 0.0012 |
| 1 | ELBASVIR AND GRAZOPREVIR | 1 | 0.0002 |
| 2 | VARENICLINE TARTRATE | 16 | 0.0002 |
| 3 | PROGESTERONE | 4 | 0.0002 |
| 4 | TRIAMTERENE | 1 | 0.0001 |
| 5 | NIACIN | 1 | 0.0001 |
| 6 | TOLVAPTAN | 1 | 0.0001 |
| 7 | ISONIAZID | 1 | 0.0001 |
| 8 | ESTRADIOL | 4 | 0.0000 |
| 9 | MESALAMINE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Calcium Channel Blocker [EPC] | 5 |
| 1 | Dihydropyridine Calcium Channel Blocker [EPC] | 5 |
| 2 | Estrogen [EPC] | 4 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 4 | Progesterone [EPC] | 4 |
| 5 | Benzodiazepine [EPC] | 3 |
| 6 | GLP-1 Receptor Agonist [EPC] | 3 |
| 7 | Aldosterone Antagonist [EPC] | 1 |
| 8 | Aminosalicylate [EPC] | 1 |
| 9 | Anticholinergic [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progesterone [EPC] | 4 | 0.0002 |
| 1 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Anticholinergic [EPC] | 1 | 0.0001 |
| 4 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 6 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 7 | Estrogen [EPC] | 4 | 0.0000 |
| 8 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Nicotinic Acid [EPC] | 1 | 0.0000 |